Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -0.785\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
[a] Cc1cc(C)nc(SCCN(C)C)n1.O=C(O)CCC(=O)O
[b] Cc1ccccc1-c1nn(-c2ccc(F)cc2F)cc1CNCCCO
[c] O=C(CCCN1C(=O)c2ccccc2C1=O)Nc1ccc(S(=O)(=O)N2CCOCC2)cc1
[d] COc1cccc(NC(=O)CSc2nc3ccccc3nc2N2CCCC2)c1
Answer: d. COc1cccc(NC(=O)CSc2nc3ccccc3nc2N2CCCC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cccc(NC(=O)CSc2nc3ccccc3nc2N2CCCC2)c1
COc1cccc(NC(=O)CSc2nc3ccccc3nc2N2CCCC2)c1
N-(5-methoxyphenyl)-2-(3-pyrrolidin-1-ylquinoxalin-2-yl)sulfanylacetamide